Clinical Trials Rare diseases: how can decentralisation speed up trials and reduce patient burden? 26 Feb 2021
BerGenBio doses first patient in second part of BGBC008 trial BerGenBio has dosed the first patient in the second part of the Phase II BGBC008... 8th October 2018